Is the watch and wait approach adequate after comprehensive surgical staging in invasive Stage I epithelial ovarian cancer? The Norwegian Radium Hospital Experience

European Journal of Gynaecological Oncology

Volumn 29, Issue 6, 2008, Pages 583-589

  Oksefjell, Halldiss ^a   Sandstad, B ^a   Trope C ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Early stage ovarian cancer

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CARBOPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; PACLITAXEL; PHOSPHORUS; PLATINUM COMPLEX; THIOTEPA;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NORWAY; OVARY CANCER; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 56749161803     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Norway Institute of Population-Based Cancer Research: Cancer in Norway 2005. Cancer Registry of Norway Institute of Population-Based Cancer Research, 2006
2. Ozols R.F., Rubin S.C., Thomas G.M., Robboy S.J.: "Epithelial ovarian cancer". In: Hoskins W.J., Perez C.A., Young R.C. (eds.) Principles and Practice of Gynaecologic Oncology, 3rd edition. Philadelphia, Lippincott, Williams & Wilkins, 2000, 981.
3. Vergote I., De Brabanter J., Fyles A., Bertelsen K., Einhorn N., Sevelda P. et al.: "Prognostic importance of degree of differentiation and cyst rupture in Stage I invasive epithelial ovarian carcinoma". Lancet, 2001, 357, 176.
4. Kristensen G.B., Kildal W., Abeler V.M., Kaern J., Vergote I., Tropé C.G. et al.: "Large-scale genomic instability predicts long-term outcome for women with invasive Stage I ovarian cancer". Ann. Oncol., 2003, 14, 1494.
5. Trope C., Kaern J., Høgberg T., Abeler V., Hagen B., Kristensen G. et al.: "Randomized study on chemotherapy in Stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument". Ann. Oncol., 2000, 11, 281.
6. Obermair A., Fuller A., Lopez-Varela E., van Gorp T., Vergote I., Eaton L. et al.: "A new prognostic model for FIGO Stage I epithelial ovarian cancer". Gynecol. Oncol., 2007, 104, 607.
7. Anttila M.A., Ji H., Juhola M.T., Saarikoski S.V., Syrjänen K.J.: "The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer". Int. J. Gynecol. Pathol., 1999, 18, 42.
8. Skirnisdottir I., Seidal T., Gerdin E., Sorbe B.: "The prognostic importance of p53, bcl-2, and bax in early Stage epithelial ovarian carcinoma treated with adjuvant chemotherapy". Int. J. Gynacol. Cancer, 2002, 12, 265.
9. Oksefjell H., Sandstad B., Tropé C.: "Ovarian cancer Stage IIIC. Consequences of treatment level on overall and progression-free survival". Eur. J. Gynaecol. Oncol., 2006, 27, 209.
10. Trimbos J.B., Vergote I., Bolis G., Vermorken J.B., Mangioni C., Madronal C. et al.: "Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial". J. Natl. Cancer Inst., 2003, 95, 113.
11. Young R.C., Decker D.G., Wharton J.T. et al.: "Staging laparotomy in early ovarian cancer". JAMA, 1983, 250, 3072.
12. Zanetta G., Rota S., Chiari S., Bonazzi C., Bratina G., Torri V. et al.: "The accuracy of staging: An important prognostic determinator in Stage I ovarian carcinoma: A multivariate analysis". Ann. Oncol., 1998, 9, 1097.
13. Trope C., Kaern J.: "Adjuvant chemotherapy for early-stage ovarian cancer: Review of the literature". J. Clin. Oncol., 2007, 25, 2909.
14. International Collaborative Ovarian Neoplasm Trial 1: "A randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer". J. Nat. Cancer Inst., 2003, 95, 125.
15. International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant Chemotherapy in Ovarian Neoplasm Trial: "Two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma". J. Natl. Cancer Inst., 2003, 95, 105.
16. Swart A.C. on behalf of ICON collaborators: "Long-term follow-up of women in a randomized trial of adjuvant chemotherapy for early stage ovarian cancer (ICON 1)". ASCO 2007; abstract nr 5509 (oral presentation).
17. McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Patridge E.E, Look K.Y. et al.: "Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with Stage III and IV ovarian cancer". N. Engl. J. Med., 1996, 334, 1.
18. du Bois A., Luck H.J., Meier W., Adams H.P., Mobus V., Costa S. et al.: A randomized clinical trial of cisplatin/paclitaxel as first-line treatment of ovarian cancer". J. Natl. Cancer Inst., 2003, 95, 1320.
19. Ozols R.F., Bundy B.N., Greer B.E., Fowler J.M., Clarke-Pearson D., Burger R.A. et al.: "Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected Stage III ovarian cancer: a Gynecologic Oncology Group study". J. Clin. Oncol., 2003, 21, 3194.
20. Bell J., Brady M.F., Young R.C., Lage J., Walker J.L., Look K.Y. et al.: "Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynaecologic Oncology Group study". Gynecol. Oncol., 2006, 102, 432.
21. Vergote I.B., Vergote-De Vos L.N., Abeler V.M., Aas M., Lindegaard M.W., Kjørstad K.E. et al.: "Randomized trial comparing cisplatin with radioactive phosphorus or whole abdominal irradiation as adjuvant treatment of ovarian cancer". Cancer 1992, 69, 741.
22. Onda T., Yoshikawa H., Yokota H., Yasugi T., Taketani Y.: "Assessment of metastasis to aortic and pelvic lymph nodes in epithelial ovarian carcinoma". Cancer, 1996, 78, 803.
23. Baiocci G., Raspagliesi F., Grosso G., di Re F., Fontanelli R.: "Early ovarian cancer: Is there a role of systematic pelvic and paraaortic lymphadenectomy?". Int. J. Gynecol. Cancer, 1998, 8, 103.
24. Trimbos J.B., Schueler J.A., van der Burg M., Hermans J., van Lent M., Heintz A.P.M. et al.: "Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer". Cancer, 1991, 67, 597.
25. Monga M., Carmichael J.A., Shelley W.E., Kirk M.E., Krepart G.V., Jeffrey J.F. et al.: "Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging". Gynecol. Oncol., 1991, 43, 195.
26. Vergote I., Trimbos B.J.: "Treatment of patients with early epithelial ovarian cancer". Curr Opin. Oncol., 2003, 15, 452.
27. Colombo N., Pecorelli S.: "What have we learned from ICON1 and ACTION?". Int. J. Gynecol. Cancer, 2003, 13 (suppl. 2), 140.
28. Bolis G., Colombo N., Pecorelli S., Torri V., Marsoni S., Bonazzi C. et al.: "Adjuvant treatment for early epithelial ovarian cancer: Results of two randomized clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)-GICOG: Gruppo Interregionale Collaborativo in Ginecologia Oncologica". Ann. Oncol., 1995, 6, 887.
29. Liavaag A.H., Dorum A., Fossa S.D., Tropé C., Dahl A.A.: "A controlled study of fatigue, quality of life, somatic and mental morbidity in epithelial ovarian cancer survivors: How lucky are the lucky ones?". J. Clin. Oncol., 2007, 25, 2049.
30. Travis L.B., Holowaty E.J., Bergfeldt K., Lynch C.F., Kohler B.A., Wiklund T. et al.: "Risk of leukemia after platinum-based chemotherapy for ovarian cancer". N. Engl. J. Med., 1999, 340, 351.